BST Awards 2025: Best alliance or partnership—Murex and Amundi Technology

Overview

The partnership between Murex and Amundi Technology—a subsidiary of Amundi, Europe’s largest asset manager, that provides technology and data platforms to other financial institutions, including asset managers, banks, wealth managers and insurers—was created to address growing demand from investment managers for over-the-counter (OTC) derivatives, risk management and liability coverage tools. 

For Amundi Technology, the partnership delivers its clients with a differentiated OTC derivatives solution, while for Murex, it boosts exposure to the buy-side market and helps build brand recognition and institutional relationships. Managed on a unified, multi-asset software-as-a-service (SaaS) platform, the combined offering from the two French fintech firms sets a new standard for the buy-side technology market.

Collaboration  

The partnership provides Amundi ALTO clients with direct access to Murex’s derivatives capabilities, offering an all-in-one combined technology experience.

The ALTO-powered-by-Murex initiative offers two ready-to-use models:

• MO Serviced: ALTO clients outsource OTC operations to Amundi’s middle-office team.
• Self-operated MO: ALTO clients directly manage OTC operations on MX.3 screens embedded within ALTO.

The partnership covers interest rate derivatives, foreign exchange derivatives, equity derivatives, counterparty and credit risk and securities finance across trade booking, pricing, life cycle and accounting.

Benefits  

• Amundi and Murex business development teams are collaborating on joint pre-sales activities. Further alignment of technology and client service teams is underway to extend the integration.
• The OTC derivatives scope is broad and deep. Amundi accesses Murex’s full instrument catalog to streamline integration of new client needs.
• The partnership is flexible and expandable so that it can meet new clients’ demands. Amundi has already extended MX.3 to additional products. Further growth opportunities are in the pipeline.

Results

Since the formalization of the partnership in February 2025, a new large European client has committed to use the Amundi–Murex combined solution as its core portfolio management/order management system. The client will have direct access to ALTO powered by MX.3. This is in addition to existing Amundi ALTO clients who already benefit from the Amundi–Murex installation.

Since the establishment of the partnership, both firms have engaged in common sales opportunities, including large asset managers in Europe, the UK and Nordic regions.

Future plans

The two firms plan to:

• Expand the partnership to offer ALTO clients enhanced capabilities that fall under Murex’s areas of expertise, including structured products and other OTC derivatives.
• Co-develop pre-sales materials to enable Amundi teams to pitch Murex’s OTC derivatives offering to clients and prospects.
• Support Amundi Technology in implementing OTC derivatives at a recently signed major French asset manager.
• Strengthen ties between Murex and Amundi with new areas of collaboration that the two firms will announce during 2026.

Why they won

The best alliance or partnership category is new to the BST Awards line-up for 2025 and what better way to showcase the importance of alliances to the global investment management industry than an outstanding partnership between two leaders in the French financial services industry. The win comes on the back of the pair’s alliance that offers institutional-grade OTC derivatives capabilities to the buy side. 

By integrating Murex’s MX.3 with Amundi Technology’s ALTO—a suite of applications for asset and wealth management, offering end-to-end support for the entire investment lifecycle—the partnership delivers a unified, multi-asset SaaS-based platform that streamlines derivatives trading, risk management and accounting within a single, integrated environment. This partnership combines Murex’s global expertise in complex instrument coverage with Amundi’s deep understanding of asset management operations. The result is a scalable and flexible offering, available as a service or managed in-house, that helps investment managers handle complex OTC products with greater efficiency and transparency. 

Early adoption by major European asset managers and ongoing joint commercial success underlines the partnership’s success. Together, Murex and Amundi are redefining buy-side technology collaboration and in so doing setting a new benchmark for integrated innovation. This win establishes an impressive standard against which future entries into this category will be judged.